Carriers of the APOE ε4 allele are at a 5 to 15-fold higher risk of developing Alzheimer’s disease (AD) [15] while the APOE ε3 allele is considered AD risk-neutral and ε2 protective [16, 17]. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.